Report Detail
Global Andrographis Paniculata Medicine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4675175 |
- 20 February, 2026 |
- Global |
- 118 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Andrographis Paniculata Medicine market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Clinical needs: Andrographis paniculata has the functions of clearing heat, detoxifying, reducing inflammation, reducing swelling and relieving pain. It has a wide range of clinical applications, especially in the treatment of respiratory diseases such as colds, coughs, pharyngitis, and pneumonia. As the incidence of these diseases increases, the clinical demand for Andrographis paniculata drugs continues to increase, promoting the development of Andrographis paniculata drugs.
This report is a detailed and comprehensive analysis for global Andrographis Paniculata Medicine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Andrographis Paniculata Medicine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Andrographis Paniculata Medicine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Andrographis Paniculata Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Andrographis Paniculata Medicine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Andrographis Paniculata Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Andrographis Paniculata Medicine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Tasly Group, Baiyunshan Pharmaceutical, Tongrentang, Changchun People Pharmaceutical, Wantong Pharmaceutical, Yiling Pharmaceutical, Shibiao Pharmaceutical, Sunflower Pharmaceutical, CSPC Pharmaceutical Group, Nuojin Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Andrographis Paniculata Medicine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tablet
Pill
Capsule
Market segment by Application
Hospital Clinic
Brick and Mortar Pharmacy
Online Pharmacy
Major players covered
Tasly Group
Baiyunshan Pharmaceutical
Tongrentang
Changchun People Pharmaceutical
Wantong Pharmaceutical
Yiling Pharmaceutical
Shibiao Pharmaceutical
Sunflower Pharmaceutical
CSPC Pharmaceutical Group
Nuojin Pharmaceutical
ECHENG
Renhe Pharmaceutical
Furen Pharmaceutical
Jiuhui Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Andrographis Paniculata Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Andrographis Paniculata Medicine, with price, sales quantity, revenue, and global market share of Andrographis Paniculata Medicine from 2021 to 2026.
Chapter 3, the Andrographis Paniculata Medicine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Andrographis Paniculata Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Andrographis Paniculata Medicine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Andrographis Paniculata Medicine.
Chapter 14 and 15, to describe Andrographis Paniculata Medicine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Andrographis Paniculata Medicine Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Tablet
- 1.3.3 Pill
- 1.3.4 Capsule
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Andrographis Paniculata Medicine Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital Clinic
- 1.4.3 Brick and Mortar Pharmacy
- 1.4.4 Online Pharmacy
- 1.5 Global Andrographis Paniculata Medicine Market Size & Forecast
- 1.5.1 Global Andrographis Paniculata Medicine Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Andrographis Paniculata Medicine Sales Quantity (2021-2032)
- 1.5.3 Global Andrographis Paniculata Medicine Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Tasly Group
- 2.1.1 Tasly Group Details
- 2.1.2 Tasly Group Major Business
- 2.1.3 Tasly Group Andrographis Paniculata Medicine Product and Services
- 2.1.4 Tasly Group Andrographis Paniculata Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Tasly Group Recent Developments/Updates
- 2.2 Baiyunshan Pharmaceutical
- 2.2.1 Baiyunshan Pharmaceutical Details
- 2.2.2 Baiyunshan Pharmaceutical Major Business
- 2.2.3 Baiyunshan Pharmaceutical Andrographis Paniculata Medicine Product and Services
- 2.2.4 Baiyunshan Pharmaceutical Andrographis Paniculata Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Baiyunshan Pharmaceutical Recent Developments/Updates
- 2.3 Tongrentang
- 2.3.1 Tongrentang Details
- 2.3.2 Tongrentang Major Business
- 2.3.3 Tongrentang Andrographis Paniculata Medicine Product and Services
- 2.3.4 Tongrentang Andrographis Paniculata Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Tongrentang Recent Developments/Updates
- 2.4 Changchun People Pharmaceutical
- 2.4.1 Changchun People Pharmaceutical Details
- 2.4.2 Changchun People Pharmaceutical Major Business
- 2.4.3 Changchun People Pharmaceutical Andrographis Paniculata Medicine Product and Services
- 2.4.4 Changchun People Pharmaceutical Andrographis Paniculata Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Changchun People Pharmaceutical Recent Developments/Updates
- 2.5 Wantong Pharmaceutical
- 2.5.1 Wantong Pharmaceutical Details
- 2.5.2 Wantong Pharmaceutical Major Business
- 2.5.3 Wantong Pharmaceutical Andrographis Paniculata Medicine Product and Services
- 2.5.4 Wantong Pharmaceutical Andrographis Paniculata Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Wantong Pharmaceutical Recent Developments/Updates
- 2.6 Yiling Pharmaceutical
- 2.6.1 Yiling Pharmaceutical Details
- 2.6.2 Yiling Pharmaceutical Major Business
- 2.6.3 Yiling Pharmaceutical Andrographis Paniculata Medicine Product and Services
- 2.6.4 Yiling Pharmaceutical Andrographis Paniculata Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Yiling Pharmaceutical Recent Developments/Updates
- 2.7 Shibiao Pharmaceutical
- 2.7.1 Shibiao Pharmaceutical Details
- 2.7.2 Shibiao Pharmaceutical Major Business
- 2.7.3 Shibiao Pharmaceutical Andrographis Paniculata Medicine Product and Services
- 2.7.4 Shibiao Pharmaceutical Andrographis Paniculata Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Shibiao Pharmaceutical Recent Developments/Updates
- 2.8 Sunflower Pharmaceutical
- 2.8.1 Sunflower Pharmaceutical Details
- 2.8.2 Sunflower Pharmaceutical Major Business
- 2.8.3 Sunflower Pharmaceutical Andrographis Paniculata Medicine Product and Services
- 2.8.4 Sunflower Pharmaceutical Andrographis Paniculata Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Sunflower Pharmaceutical Recent Developments/Updates
- 2.9 CSPC Pharmaceutical Group
- 2.9.1 CSPC Pharmaceutical Group Details
- 2.9.2 CSPC Pharmaceutical Group Major Business
- 2.9.3 CSPC Pharmaceutical Group Andrographis Paniculata Medicine Product and Services
- 2.9.4 CSPC Pharmaceutical Group Andrographis Paniculata Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 CSPC Pharmaceutical Group Recent Developments/Updates
- 2.10 Nuojin Pharmaceutical
- 2.10.1 Nuojin Pharmaceutical Details
- 2.10.2 Nuojin Pharmaceutical Major Business
- 2.10.3 Nuojin Pharmaceutical Andrographis Paniculata Medicine Product and Services
- 2.10.4 Nuojin Pharmaceutical Andrographis Paniculata Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Nuojin Pharmaceutical Recent Developments/Updates
- 2.11 ECHENG
- 2.11.1 ECHENG Details
- 2.11.2 ECHENG Major Business
- 2.11.3 ECHENG Andrographis Paniculata Medicine Product and Services
- 2.11.4 ECHENG Andrographis Paniculata Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 ECHENG Recent Developments/Updates
- 2.12 Renhe Pharmaceutical
- 2.12.1 Renhe Pharmaceutical Details
- 2.12.2 Renhe Pharmaceutical Major Business
- 2.12.3 Renhe Pharmaceutical Andrographis Paniculata Medicine Product and Services
- 2.12.4 Renhe Pharmaceutical Andrographis Paniculata Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Renhe Pharmaceutical Recent Developments/Updates
- 2.13 Furen Pharmaceutical
- 2.13.1 Furen Pharmaceutical Details
- 2.13.2 Furen Pharmaceutical Major Business
- 2.13.3 Furen Pharmaceutical Andrographis Paniculata Medicine Product and Services
- 2.13.4 Furen Pharmaceutical Andrographis Paniculata Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Furen Pharmaceutical Recent Developments/Updates
- 2.14 Jiuhui Pharmaceutical
- 2.14.1 Jiuhui Pharmaceutical Details
- 2.14.2 Jiuhui Pharmaceutical Major Business
- 2.14.3 Jiuhui Pharmaceutical Andrographis Paniculata Medicine Product and Services
- 2.14.4 Jiuhui Pharmaceutical Andrographis Paniculata Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Jiuhui Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Andrographis Paniculata Medicine by Manufacturer
- 3.1 Global Andrographis Paniculata Medicine Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Andrographis Paniculata Medicine Revenue by Manufacturer (2021-2026)
- 3.3 Global Andrographis Paniculata Medicine Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Andrographis Paniculata Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Andrographis Paniculata Medicine Manufacturer Market Share in 2025
- 3.4.3 Top 6 Andrographis Paniculata Medicine Manufacturer Market Share in 2025
- 3.5 Andrographis Paniculata Medicine Market: Overall Company Footprint Analysis
- 3.5.1 Andrographis Paniculata Medicine Market: Region Footprint
- 3.5.2 Andrographis Paniculata Medicine Market: Company Product Type Footprint
- 3.5.3 Andrographis Paniculata Medicine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Andrographis Paniculata Medicine Market Size by Region
- 4.1.1 Global Andrographis Paniculata Medicine Sales Quantity by Region (2021-2032)
- 4.1.2 Global Andrographis Paniculata Medicine Consumption Value by Region (2021-2032)
- 4.1.3 Global Andrographis Paniculata Medicine Average Price by Region (2021-2032)
- 4.2 North America Andrographis Paniculata Medicine Consumption Value (2021-2032)
- 4.3 Europe Andrographis Paniculata Medicine Consumption Value (2021-2032)
- 4.4 Asia-Pacific Andrographis Paniculata Medicine Consumption Value (2021-2032)
- 4.5 South America Andrographis Paniculata Medicine Consumption Value (2021-2032)
- 4.6 Middle East & Africa Andrographis Paniculata Medicine Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Andrographis Paniculata Medicine Sales Quantity by Type (2021-2032)
- 5.2 Global Andrographis Paniculata Medicine Consumption Value by Type (2021-2032)
- 5.3 Global Andrographis Paniculata Medicine Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Andrographis Paniculata Medicine Sales Quantity by Application (2021-2032)
- 6.2 Global Andrographis Paniculata Medicine Consumption Value by Application (2021-2032)
- 6.3 Global Andrographis Paniculata Medicine Average Price by Application (2021-2032)
7 North America
- 7.1 North America Andrographis Paniculata Medicine Sales Quantity by Type (2021-2032)
- 7.2 North America Andrographis Paniculata Medicine Sales Quantity by Application (2021-2032)
- 7.3 North America Andrographis Paniculata Medicine Market Size by Country
- 7.3.1 North America Andrographis Paniculata Medicine Sales Quantity by Country (2021-2032)
- 7.3.2 North America Andrographis Paniculata Medicine Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Andrographis Paniculata Medicine Sales Quantity by Type (2021-2032)
- 8.2 Europe Andrographis Paniculata Medicine Sales Quantity by Application (2021-2032)
- 8.3 Europe Andrographis Paniculata Medicine Market Size by Country
- 8.3.1 Europe Andrographis Paniculata Medicine Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Andrographis Paniculata Medicine Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Andrographis Paniculata Medicine Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Andrographis Paniculata Medicine Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Andrographis Paniculata Medicine Market Size by Region
- 9.3.1 Asia-Pacific Andrographis Paniculata Medicine Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Andrographis Paniculata Medicine Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Andrographis Paniculata Medicine Sales Quantity by Type (2021-2032)
- 10.2 South America Andrographis Paniculata Medicine Sales Quantity by Application (2021-2032)
- 10.3 South America Andrographis Paniculata Medicine Market Size by Country
- 10.3.1 South America Andrographis Paniculata Medicine Sales Quantity by Country (2021-2032)
- 10.3.2 South America Andrographis Paniculata Medicine Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Andrographis Paniculata Medicine Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Andrographis Paniculata Medicine Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Andrographis Paniculata Medicine Market Size by Country
- 11.3.1 Middle East & Africa Andrographis Paniculata Medicine Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Andrographis Paniculata Medicine Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Andrographis Paniculata Medicine Market Drivers
- 12.2 Andrographis Paniculata Medicine Market Restraints
- 12.3 Andrographis Paniculata Medicine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Andrographis Paniculata Medicine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Andrographis Paniculata Medicine
- 13.3 Andrographis Paniculata Medicine Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Andrographis Paniculata Medicine Typical Distributors
- 14.3 Andrographis Paniculata Medicine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Andrographis Paniculata Medicine. Industry analysis & Market Report on Andrographis Paniculata Medicine is a syndicated market report, published as Global Andrographis Paniculata Medicine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Andrographis Paniculata Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
